Kraig Biocraft Laboratories, Inc. was founded by the current CEO Kim Thompson, who invented the company’s technology. Kraig Biocraft is a fully reporting organization and trades on the over-the-counter market under the stock symbol KBLB. Currently, there are about 50 million common shares outstanding, approximately 64% of which is being held by Mr. Thompson.
At Kraft Biocraft, Mr. Thompson functions as the overall coordinator for the company’s business operations, ongoing research and development. Several prominent genetic scientists, one at the University of Wyoming and another at the University of Notre Dame, have teamed up with the company to further develop its technologies. The laboratory staffs of these professors are also greatly contributing to the company’s efforts.
The University of Wyoming Foundation has contributed significant intellectual property to Kraft Biocraft and has a major shareholder stake in the company. A number of the major discoveries from these associated researchers have proven essential to the company’s product development efforts. According to a comprehensive report prepared by Emerging Growth Research, the company has acquired exclusive rights to university owned technologies and is able to use these rights in product development and commercialization.
The company defines its technology as a unique protein expression system that is potentially highly scalable and cost-effective in producing a variety of different proteins that can be marketed into the pharmaceutical, technical textiles and materials markets. This unique protein expression system, known as spider silk, is one of the strongest and most resilient fibers known to man.
Let us hear your thoughts: Kraig Biocraft Laboratories, Inc. Message Board